Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 15, Issue 10, Pages 1889-1900
Publisher
Wiley
Online
2017-06-30
DOI
10.1111/jth.13764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
- (2017) M. Scully et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
- (2017) Pavan K Bendapudi et al. Lancet Haematology
- N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura
- (2016) Claudia Tersteeg et al. BLOOD
- Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura
- (2016) Wenjing Cao et al. HAEMATOLOGICA
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy-related thrombotic microangiopathies: Clues from complement biology
- (2016) Fadi Fakhouri TRANSFUSION AND APHERESIS SCIENCE
- Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura
- (2016) Wenjing Cao et al. HAEMATOLOGICA
- ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura
- (2015) X. Long Zheng Annual Review of Medicine
- Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic PurpuraSignificance
- (2015) Claudia Tersteeg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models
- (2015) B. Pickens et al. BLOOD
- Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity
- (2015) L. Zafrani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies
- (2015) M. Jiménez-Alcázar et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP
- (2015) Michael Schwameis et al. THROMBOSIS AND HAEMOSTASIS
- Use of the ADAMTS13 Activity Assay Improved the Accuracy and Efficiency of the Diagnosis and Treatment of Suspected Acquired Thrombotic Thrombocytopenic Purpura
- (2014) Brad D. Barrows et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF)
- (2014) Hassan Izzedine et al. MEDICINE
- AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura
- (2013) S.-Y. Jin et al. BLOOD
- Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)
- (2013) Charles L. Bennett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults
- (2013) V. Fremeaux-Bacchi et al. Clinical Journal of the American Society of Nephrology
- Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy
- (2013) R. Tati et al. JOURNAL OF IMMUNOLOGY
- An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura
- (2013) J. Muia et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Structure-function and regulation of ADAMTS-13 protease
- (2013) X. L. Zheng JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome
- (2013) Mathieu Lemaire et al. NATURE GENETICS
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
- (2013) C.M. Legendre et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gastrointestinal and Extra-Intestinal Manifestations of Childhood Shigellosis in a Region Where All Four Species of Shigella Are Endemic
- (2013) Wasif A. Khan et al. PLoS One
- Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies
- (2013) Katy Langley et al. THROMBOSIS AND HAEMOSTASIS
- A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13
- (2012) A. Schiviz et al. BLOOD
- Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
- (2012) C. Jian et al. BLOOD
- Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura
- (2012) F. Callewaert et al. BLOOD
- Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies
- (2012) T. A. Fuchs et al. BLOOD
- Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura
- (2012) M. Moatti-Cohen et al. BLOOD
- Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
- (2012) Marie Scully et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cancer-Related Microangiopathic Hemolytic Anemia
- (2012) Klaus Lechner et al. MEDICINE
- Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer
- (2012) James N. George et al. PRESSE MEDICALE
- Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A 20-Year Review from the Southern Network on Adverse Reactions (SONAR)
- (2012) Sony Jacob et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Complement Activation During Liver Transplantation-Special Emphasis on Patients With Atypical Hemolytic Uremic Syndrome
- (2011) A. R. Koskinen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes
- (2011) G. ZINI et al. International Journal of Laboratory Hematology
- Thrombotic Microangiopathy After Kidney Transplantation
- (2010) M. Noris et al. AMERICAN JOURNAL OF TRANSPLANTATION
- How I treat patients with thrombotic thrombocytopenic purpura: 2010
- (2010) J. N. George BLOOD
- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
- (2010) M. Noris et al. Clinical Journal of the American Society of Nephrology
- Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
- (2010) Paul Coppo et al. PLoS One
- Posttransplantation Calcineurin Inhibitor–Induced Hemolytic Uremic Syndrome: Single-Center Experience
- (2010) T. Said et al. TRANSPLANTATION PROCEEDINGS
- Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy
- (2009) P. Laje et al. BLOOD
- Guidelines for the diagnosis and management of disseminated intravascular coagulation
- (2009) M Levi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy
- (2009) Yara A. Park et al. JOURNAL OF CLINICAL APHERESIS
- Atypical Hemolytic–Uremic Syndrome
- (2009) Marina Noris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura
- (2009) Karen K. Swisher et al. TRANSFUSION
- Pathogenesis of Thrombotic Microangiopathies
- (2008) X. Long Zheng et al. Annual Review of Pathology-Mechanisms of Disease
- Association Between Thrombotic Microangiopathy and Reduced ADAMTS13 Activity in Malignant Hypertension
- (2008) Bert-Jan H. van den Born et al. HYPERTENSION
- Human Immunodeficiency Virus-Associated Thrombotic Microangiopathies: Clinical Characteristics and Outcome According to ADAMTS13 Activity
- (2008) S. Malak et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started